|
G |
Abcb1a |
ATP binding cassette subfamily B member 1A |
multiple interactions |
EXP |
Sildenafil Citrate inhibits the reaction [[Aflatoxin B1 co-treated with Ethanol] results in increased expression of ABCB1 mRNA] |
CTD |
PMID:35608386 |
|
NCBI chr 4:25,357,467...25,529,941
Ensembl chr 4:25,158,362...25,442,709
|
|
G |
Abcg2 |
ATP binding cassette subfamily G member 2 |
multiple interactions |
EXP |
Sildenafil Citrate inhibits the reaction [[Aflatoxin B1 co-treated with Ethanol] results in increased expression of ABCG2 mRNA] |
CTD |
PMID:35608386 |
|
NCBI chr 4:87,676,241...87,802,757
Ensembl chr 4:87,745,319...87,802,409
|
|
G |
Acta2 |
actin alpha 2, smooth muscle |
decreases expression |
EXP |
Sildenafil Citrate results in decreased expression of ACTA2 protein |
CTD |
PMID:14996430 |
|
NCBI chr 1:231,746,527...231,759,307
Ensembl chr 1:231,746,548...231,759,554
|
|
G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
increases expression multiple interactions |
ISO EXP |
Sildenafil Citrate results in increased expression of ADIPOQ mRNA Sildenafil Citrate inhibits the reaction [Epinephrine results in decreased expression of ADIPOQ protein] |
CTD |
PMID:20471953 PMID:29233027 |
|
NCBI chr11:77,721,912...77,735,644
Ensembl chr11:77,721,912...77,735,564
|
|
G |
Agt |
angiotensinogen |
increases expression multiple interactions |
ISO |
Sildenafil Citrate results in increased expression of AGT protein modified form PRKG1 protein promotes the reaction [Sildenafil Citrate inhibits the reaction [AGT protein modified form results in increased expression of CCN2 mRNA]]; PRKG1 protein promotes the reaction [Sildenafil Citrate inhibits the reaction [AGT protein modified form results in increased expression of COL1A1 mRNA]]; PRKG1 protein promotes the reaction [Sildenafil Citrate inhibits the reaction [AGT protein modified form results in increased expression of FN1 mRNA]]; PRKG1 protein promotes the reaction [Sildenafil Citrate inhibits the reaction [AGT protein modified form results in increased expression of TGFB1 mRNA]]; Sildenafil Citrate inhibits the reaction [AGT protein modified form results in increased expression of CCN2 mRNA]; Sildenafil Citrate inhibits the reaction [AGT protein modified form results in increased expression of COL1A1 mRNA]; Sildenafil Citrate inhibits the reaction [AGT protein modified form results in increased expression of FN1 mRNA]; Sildenafil Citrate inhibits the reaction [AGT protein modified form results in increased expression of TGFB1 mRNA] |
CTD |
PMID:15613622 PMID:25139994 |
|
NCBI chr19:52,529,139...52,549,618
Ensembl chr19:52,529,185...52,540,977
|
|
G |
Agtr1b |
angiotensin II receptor, type 1b |
multiple interactions |
EXP |
Sildenafil Citrate inhibits the reaction [NG-Nitroarginine Methyl Ester results in increased expression of AGTR1B protein] |
CTD |
PMID:32479886 |
|
NCBI chr 2:102,844,969...102,920,232
Ensembl chr 2:102,844,969...102,920,232
|
|
G |
Akt1 |
AKT serine/threonine kinase 1 |
increases phosphorylation multiple interactions |
EXP |
Sildenafil Citrate results in increased phosphorylation of AKT1 protein Sildenafil Citrate inhibits the reaction [[Aflatoxin B1 co-treated with Ethanol] results in increased expression of AKT1 mRNA]; Sildenafil Citrate inhibits the reaction [Oxygen deficiency results in increased phosphorylation of AKT1 protein] |
CTD |
PMID:18373738 PMID:35608386 PMID:36940862 |
|
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
|
|
G |
Angpt1 |
angiopoietin 1 |
increases expression |
EXP |
Sildenafil Citrate results in increased expression of ANGPT1 mRNA; Sildenafil Citrate results in increased expression of ANGPT1 protein |
CTD |
PMID:18373738 |
|
NCBI chr 7:73,528,345...73,783,953
Ensembl chr 7:73,531,486...73,784,067
|
|
G |
Arg1 |
arginase 1 |
decreases expression |
ISO |
Sildenafil Citrate results in decreased expression of ARG1 protein |
CTD |
PMID:17101732 |
|
NCBI chr 1:20,475,878...20,488,422
Ensembl chr 1:20,475,968...20,488,422
|
|
G |
Bad |
BCL2-associated agonist of cell death |
multiple interactions |
ISO |
Sildenafil Citrate promotes the reaction [Doxorubicin results in decreased phosphorylation of BAD protein] |
CTD |
PMID:20884855 |
|
NCBI chr 1:204,133,502...204,142,829
Ensembl chr 1:204,131,501...204,142,823
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
multiple interactions |
EXP |
Sildenafil Citrate inhibits the reaction [Cisplatin results in increased expression of BAX protein]; Sildenafil Citrate inhibits the reaction [Streptozocin results in increased expression of BAX mRNA]; Sildenafil Citrate promotes the reaction [Tadalafil inhibits the reaction [Streptozocin results in increased expression of BAX mRNA]]; Tadalafil promotes the reaction [Sildenafil Citrate inhibits the reaction [Streptozocin results in increased expression of BAX mRNA]]; Testosterone promotes the reaction [Sildenafil Citrate inhibits the reaction [Streptozocin results in increased expression of BAX mRNA]]; Testosterone promotes the reaction [Sildenafil Citrate promotes the reaction [Tadalafil inhibits the reaction [Streptozocin results in increased expression of BAX mRNA]]]; Testosterone promotes the reaction [Tadalafil promotes the reaction [Sildenafil Citrate inhibits the reaction [Streptozocin results in increased expression of BAX mRNA]]] |
CTD |
PMID:19152827 PMID:20574430 |
|
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
multiple interactions increases expression decreases expression |
ISO EXP |
Sildenafil Citrate inhibits the reaction [Doxorubicin results in decreased expression of BCL2 protein] Sildenafil Citrate inhibits the reaction [Streptozocin results in decreased expression of BCL2 mRNA]; Sildenafil Citrate promotes the reaction [Tadalafil inhibits the reaction [Streptozocin results in decreased expression of BCL2 mRNA]]; Tadalafil promotes the reaction [Sildenafil Citrate inhibits the reaction [Streptozocin results in decreased expression of BCL2 mRNA]]; Testosterone promotes the reaction [Sildenafil Citrate inhibits the reaction [Streptozocin results in decreased expression of BCL2 mRNA]]; Testosterone promotes the reaction [Sildenafil Citrate promotes the reaction [Tadalafil inhibits the reaction [Streptozocin results in decreased expression of BCL2 mRNA]]]; Testosterone promotes the reaction [Tadalafil promotes the reaction [Sildenafil Citrate inhibits the reaction [Streptozocin results in decreased expression of BCL2 mRNA]]] Sildenafil Citrate results in increased expression of BCL2 Sildenafil Citrate results in decreased expression of BCL2 protein |
CTD |
PMID:15811867 PMID:18373738 PMID:20574430 PMID:38059649 |
|
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Bcl2l1 |
Bcl2-like 1 |
multiple interactions affects response to substance |
ISO |
BCL2L1 protein inhibits the reaction [Sildenafil Citrate results in increased activity of Doxorubicin]; Sildenafil Citrate promotes the reaction [Doxorubicin results in decreased expression of BCL2L1 protein] BCL2L1 protein affects the susceptibility to Sildenafil Citrate |
CTD |
PMID:20884855 |
|
NCBI chr 3:141,253,508...141,304,582
Ensembl chr 3:141,253,523...141,303,479
|
|
G |
Casp3 |
caspase 3 |
multiple interactions |
ISO EXP |
CASP3 protein promotes the reaction [Sildenafil Citrate results in increased susceptibility to Doxorubicin]; Sildenafil Citrate promotes the reaction [Doxorubicin results in increased activity of CASP3 protein] Sildenafil Citrate inhibits the reaction [Cisplatin results in increased activity of CASP3 protein]; Sildenafil Citrate inhibits the reaction [Epinephrine results in increased expression of CASP3 protein] 5-hydroxydecanoic acid inhibits the reaction [Sildenafil Citrate inhibits the reaction [Doxorubicin results in increased activity of CASP3 protein]]; Cisplatin promotes the reaction [Sildenafil Citrate results in increased cleavage of CASP3 protein]; Sildenafil Citrate inhibits the reaction [Doxorubicin results in increased activity of CASP3 protein]; Sildenafil Citrate promotes the reaction [Cisplatin results in increased cleavage of CASP3 protein]; Sildenafil Citrate results in decreased expression of and results in increased cleavage of CASP3 protein |
CTD |
PMID:15811867 PMID:19152827 PMID:20155316 PMID:20884855 PMID:29233027 PMID:38059649 More...
|
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp9 |
caspase 9 |
affects response to substance multiple interactions |
ISO |
CASP9 protein affects the susceptibility to Sildenafil Citrate CASP9 protein mutant form inhibits the reaction [Sildenafil Citrate results in increased activity of Doxorubicin]; Sildenafil Citrate promotes the reaction [Doxorubicin results in increased activity of CASP9 protein] |
CTD |
PMID:20884855 |
|
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
|
|
G |
Cat |
catalase |
increases expression multiple interactions decreases expression |
EXP ISO |
Sildenafil Citrate results in increased expression of CAT protein Sildenafil Citrate inhibits the reaction [Paroxetine results in decreased activity of CAT protein] Sildenafil Citrate results in decreased expression of CAT protein |
CTD |
PMID:18265987 PMID:36740106 PMID:38059649 |
|
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
|
|
G |
Ccn2 |
cellular communication network factor 2 |
multiple interactions |
ISO |
PRKG1 protein promotes the reaction [Sildenafil Citrate inhibits the reaction [AGT protein modified form results in increased expression of CCN2 mRNA]]; Sildenafil Citrate inhibits the reaction [AGT protein modified form results in increased expression of CCN2 mRNA] |
CTD |
PMID:25139994 |
|
NCBI chr 1:20,802,199...20,805,315
Ensembl chr 1:20,802,199...20,805,734
|
|
G |
Ccna2 |
cyclin A2 |
multiple interactions |
EXP |
Sildenafil Citrate inhibits the reaction [Oxygen deficiency results in increased expression of CCNA2 protein] |
CTD |
PMID:36940862 |
|
NCBI chr 2:119,427,239...119,433,645
Ensembl chr 2:119,426,089...119,433,577
|
|
G |
Ccnd1 |
cyclin D1 |
multiple interactions |
EXP |
Sildenafil Citrate inhibits the reaction [Oxygen deficiency results in increased expression of CCND1 protein] |
CTD |
PMID:36940862 |
|
NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602
|
|
G |
Cebpa |
CCAAT/enhancer binding protein alpha |
increases expression |
ISO |
Sildenafil Citrate results in increased expression of CEBPA mRNA; Sildenafil Citrate results in increased expression of CEBPA protein |
CTD |
PMID:20471953 |
|
NCBI chr 1:87,759,631...87,762,303
Ensembl chr 1:87,759,433...87,762,412
|
|
G |
Cebpb |
CCAAT/enhancer binding protein beta |
multiple interactions increases expression |
ISO |
8-(4-chlorophenylthio)guanosine 3',5'-cyclic monophosphorothioate inhibits the reaction [Sildenafil Citrate results in increased expression of CEBPB protein] Sildenafil Citrate results in increased expression of CEBPB mRNA; Sildenafil Citrate results in increased expression of CEBPB protein |
CTD |
PMID:20471953 |
|
NCBI chr 3:156,398,035...156,399,466
Ensembl chr 3:156,397,052...156,399,473
|
|
G |
Cftr |
CF transmembrane conductance regulator |
affects localization increases activity multiple interactions |
ISO |
Sildenafil Citrate affects the localization of CFTR protein mutant form Sildenafil Citrate results in increased activity of CFTR protein Sildenafil Citrate promotes the reaction [CFTR protein affects the secretion of Chlorides] |
CTD |
PMID:12714375 PMID:15618584 |
|
NCBI chr 4:46,561,269...46,728,759
Ensembl chr 4:46,560,885...46,728,756
|
|
G |
Col1a1 |
collagen type I alpha 1 chain |
multiple interactions |
ISO |
PRKG1 protein promotes the reaction [Sildenafil Citrate inhibits the reaction [AGT protein modified form results in increased expression of COL1A1 mRNA]]; Sildenafil Citrate inhibits the reaction [AGT protein modified form results in increased expression of COL1A1 mRNA] |
CTD |
PMID:25139994 |
|
NCBI chr10:79,883,622...79,900,625
Ensembl chr10:79,883,622...79,900,624
|
|
G |
Creb1 |
cAMP responsive element binding protein 1 |
multiple interactions increases phosphorylation |
ISO |
atosiban inhibits the reaction [Sildenafil Citrate results in increased phosphorylation of CREB1 protein] |
CTD |
PMID:27220266 |
|
NCBI chr 9:65,903,511...65,972,562
Ensembl chr 9:65,903,547...65,970,816
|
|
G |
Cybb |
cytochrome b-245 beta chain |
multiple interactions |
EXP |
Sildenafil Citrate inhibits the reaction [NG-Nitroarginine Methyl Ester results in increased expression of CYBB protein] |
CTD |
PMID:32479886 |
|
NCBI chr X:13,358,101...13,392,570
Ensembl chr X:13,359,430...13,392,586
|
|
G |
Cyp1b1 |
cytochrome P450, family 1, subfamily b, polypeptide 1 |
decreases activity |
ISO |
Sildenafil Citrate results in decreased activity of CYP1B1 protein |
CTD |
PMID:33814510 |
|
NCBI chr 6:15,342,312...15,350,886
Ensembl chr 6:15,342,344...15,350,917
|
|
G |
Des |
desmin |
multiple interactions |
ISO |
Sildenafil Citrate inhibits the reaction [Doxorubicin affects the localization of DES protein] |
CTD |
PMID:15811867 |
|
NCBI chr 9:76,850,979...76,858,695
Ensembl chr 9:76,850,982...76,858,699
|
|
G |
Edn1 |
endothelin 1 |
multiple interactions |
ISO |
Sildenafil Citrate inhibits the reaction [EDN1 protein results in increased expression of TRPC1 mRNA] |
CTD |
PMID:18818482 |
|
NCBI chr17:22,454,924...22,460,812
Ensembl chr17:22,454,420...22,460,885
|
|
G |
Fabp4 |
fatty acid binding protein 4 |
multiple interactions increases expression |
ISO |
8-(4-chlorophenylthio)guanosine 3',5'-cyclic monophosphorothioate inhibits the reaction [Sildenafil Citrate results in increased expression of FABP4 protein] Sildenafil Citrate results in increased expression of FABP4 mRNA; Sildenafil Citrate results in increased expression of FABP4 protein |
CTD |
PMID:20471953 |
|
NCBI chr 2:91,580,879...91,585,567
Ensembl chr 2:91,580,885...91,585,578
|
|
G |
Fasn |
fatty acid synthase |
increases expression |
ISO |
Sildenafil Citrate results in increased expression of FASN mRNA |
CTD |
PMID:20471953 |
|
NCBI chr10:106,072,093...106,090,259
Ensembl chr10:106,072,091...106,090,261
|
|
G |
Fgf1 |
fibroblast growth factor 1 |
increases expression |
EXP |
Sildenafil Citrate results in increased expression of FGF1 mRNA |
CTD |
PMID:20583517 |
|
NCBI chr18:30,686,555...30,772,667
Ensembl chr18:30,686,581...30,772,357
|
|
G |
Fgfr3 |
fibroblast growth factor receptor 3 |
increases expression |
EXP |
Sildenafil Citrate results in increased expression of FGFR3 mRNA |
CTD |
PMID:20583517 |
|
NCBI chr14:76,987,242...77,002,671
Ensembl chr14:76,987,993...77,003,341
|
|
G |
Fn1 |
fibronectin 1 |
multiple interactions |
ISO |
PRKG1 protein promotes the reaction [Sildenafil Citrate inhibits the reaction [AGT protein modified form results in increased expression of FN1 mRNA]]; Sildenafil Citrate inhibits the reaction [AGT protein modified form results in increased expression of FN1 mRNA] |
CTD |
PMID:25139994 |
|
NCBI chr 9:73,196,044...73,264,695
Ensembl chr 9:73,196,044...73,264,678
|
|
G |
Fshb |
follicle stimulating hormone subunit beta |
multiple interactions |
ISO |
Sildenafil Citrate inhibits the reaction [Streptozocin results in decreased expression of FSHB protein] |
CTD |
PMID:30365938 |
|
NCBI chr 3:93,548,560...93,552,370
Ensembl chr 3:93,548,560...93,552,370
|
|
G |
Got1 |
glutamic-oxaloacetic transaminase 1 |
multiple interactions |
EXP |
Sildenafil Citrate inhibits the reaction [Aflatoxin B1 results in increased activity of GOT1 protein] |
CTD |
PMID:35608386 |
|
NCBI chr 1:242,357,293...242,381,535
Ensembl chr 1:242,357,306...242,380,633
|
|
G |
Gpt |
glutamic--pyruvic transaminase |
multiple interactions |
EXP ISO |
Sildenafil Citrate inhibits the reaction [Aflatoxin B1 results in increased activity of GPT protein] Sildenafil Citrate inhibits the reaction [Paroxetine results in increased activity of GPT protein] |
CTD |
PMID:35608386 PMID:36740106 |
|
NCBI chr 7:108,416,646...108,419,495
Ensembl chr 7:108,416,642...108,419,494
|
|
G |
Hif1a |
hypoxia inducible factor 1 subunit alpha |
multiple interactions decreases expression |
EXP ISO |
Sildenafil Citrate inhibits the reaction [[Aflatoxin B1 co-treated with Ethanol] results in increased expression of HIF1A protein] Sildenafil Citrate results in decreased expression of HIF1A mRNA |
CTD |
PMID:35608386 PMID:38059649 |
|
NCBI chr 6:92,624,059...92,669,262
Ensembl chr 6:92,624,390...92,669,261
|
|
G |
Hmox1 |
heme oxygenase 1 |
multiple interactions increases expression |
EXP |
Curcumin promotes the reaction [Sildenafil Citrate results in increased expression of HMOX1 mRNA]; Curcumin promotes the reaction [Sildenafil Citrate results in increased expression of HMOX1 protein]; zinc protoporphyrin inhibits the reaction [Sildenafil Citrate results in increased expression of HMOX1 mRNA]; zinc protoporphyrin inhibits the reaction [Sildenafil Citrate results in increased expression of HMOX1 protein] Sildenafil Citrate results in increased expression of HMOX1; Sildenafil Citrate results in increased expression of HMOX1 mRNA; Sildenafil Citrate results in increased expression of HMOX1 protein |
CTD |
PMID:17627722 PMID:18373738 |
|
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
|
|
G |
Il4 |
interleukin 4 |
multiple interactions |
ISO |
Sildenafil Citrate inhibits the reaction [4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone results in decreased expression of IL4 protein] |
CTD |
PMID:15169552 |
|
NCBI chr10:37,771,203...37,776,750
Ensembl chr10:37,771,203...37,776,750
|
|
G |
Il4r |
interleukin 4 receptor |
decreases expression |
ISO |
Sildenafil Citrate results in decreased expression of IL4RA protein |
CTD |
PMID:17101732 |
|
NCBI chr 1:180,115,061...180,139,981
Ensembl chr 1:180,115,120...180,139,980
|
|
G |
Il5 |
interleukin 5 |
multiple interactions |
ISO |
Sildenafil Citrate inhibits the reaction [4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone results in decreased expression of IL5 protein] |
CTD |
PMID:15169552 |
|
NCBI chr10:37,874,342...37,877,213
Ensembl chr10:37,874,342...37,877,213
|
|
G |
Ins1 |
insulin 1 |
multiple interactions |
ISO |
8-(4-chlorophenylthio)guanosine 3',5'-cyclic monophosphorothioate inhibits the reaction [Sildenafil Citrate promotes the reaction [INS1 protein results in increased import of Blood Glucose]]; Sildenafil Citrate promotes the reaction [INS1 protein results in increased import of Glucose] |
CTD |
PMID:20471953 |
|
NCBI chr 1:251,244,973...251,245,540
Ensembl chr 1:251,244,973...251,245,536
|
|
G |
Ldha |
lactate dehydrogenase A |
multiple interactions decreases expression |
EXP ISO |
Sildenafil Citrate inhibits the reaction [[Aflatoxin B1 co-treated with Ethanol] results in increased expression of LDHA mRNA] Sildenafil Citrate results in decreased expression of LDHA mRNA |
CTD |
PMID:35608386 PMID:38059649 |
|
NCBI chr 1:97,371,823...97,381,247
Ensembl chr 1:97,366,021...97,433,472
|
|
G |
Lhb |
luteinizing hormone subunit beta |
multiple interactions |
ISO |
Sildenafil Citrate inhibits the reaction [Streptozocin results in decreased expression of LHB protein] |
CTD |
PMID:30365938 |
|
NCBI chr 1:95,898,269...95,901,973
Ensembl chr 1:95,900,984...95,901,972 Ensembl chr 1:95,900,984...95,901,972
|
|
G |
Mmp9 |
matrix metallopeptidase 9 |
multiple interactions |
ISO |
Sildenafil Citrate promotes the reaction [Atorvastatin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of MMP9 protein]] |
CTD |
PMID:26614570 |
|
NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
|
|
G |
Mpo |
myeloperoxidase |
multiple interactions |
EXP |
Sildenafil Citrate inhibits the reaction [Indomethacin results in increased activity of MPO protein] |
CTD |
PMID:16113693 |
|
NCBI chr10:72,594,883...72,608,862
Ensembl chr10:72,594,661...72,604,819
|
|
G |
Myc |
MYC proto-oncogene, bHLH transcription factor |
multiple interactions |
EXP |
Sildenafil Citrate inhibits the reaction [[Aflatoxin B1 co-treated with Ethanol] results in increased expression of MYC mRNA] |
CTD |
PMID:35608386 |
|
NCBI chr 7:93,593,705...93,598,633
Ensembl chr 7:93,593,705...93,598,630
|
|
G |
Nes |
nestin |
multiple interactions |
EXP |
Sildenafil Citrate inhibits the reaction [[Aluminum Chloride results in increased abundance of Aluminum] which results in decreased expression of NES protein] |
CTD |
PMID:32959702 |
|
NCBI chr 2:173,437,867...173,447,777
Ensembl chr 2:173,438,734...173,447,777
|
|
G |
Nos1 |
nitric oxide synthase 1 |
multiple interactions increases expression |
EXP |
[Sildenafil Citrate co-treated with Resveratrol] inhibits the reaction [Streptozocin results in decreased expression of NOS1 protein]; [Sildenafil Citrate co-treated with zinc protoporphyrin] results in increased expression of NOS1 mRNA; Curcumin promotes the reaction [Sildenafil Citrate results in increased expression of NOS1 mRNA] |
CTD |
PMID:17627722 PMID:26006044 |
|
NCBI chr12:38,615,111...38,795,492
Ensembl chr12:38,626,714...38,710,945
|
|
G |
Nos2 |
nitric oxide synthase 2 |
decreases expression multiple interactions |
ISO EXP |
Sildenafil Citrate results in decreased expression of NOS2 protein [Cisplatin co-treated with Sildenafil Citrate] results in increased expression of NOS2 mRNA; [Cisplatin co-treated with Sildenafil Citrate] results in increased expression of NOS2 protein |
CTD |
PMID:17101732 PMID:19152827 |
|
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
|
|
G |
Nos3 |
nitric oxide synthase 3 |
increases activity multiple interactions increases expression increases phosphorylation |
ISO EXP |
Sildenafil Citrate results in increased activity of NOS3 protein [Cisplatin co-treated with Sildenafil Citrate] results in increased expression of NOS3 mRNA; [Cisplatin co-treated with Sildenafil Citrate] results in increased expression of NOS3 protein; [Sildenafil Citrate co-treated with Resveratrol] inhibits the reaction [Streptozocin results in decreased expression of NOS3 protein]; [Sildenafil Citrate results in increased expression of NOS3 protein] which results in increased secretion of Nitric Oxide; Sildenafil Citrate inhibits the reaction [alpha-naphthyl thiourea results in decreased expression of NOS3 mRNA]; Sildenafil Citrate inhibits the reaction [alpha-naphthyl thiourea results in decreased expression of NOS3 protein]; Sildenafil Citrate inhibits the reaction [NG-Nitroarginine Methyl Ester results in decreased expression of NOS3 protein] Sildenafil Citrate results in increased phosphorylation of NOS3 protein |
CTD |
PMID:18373738 PMID:19152827 PMID:19845545 PMID:23650378 PMID:26006044 PMID:30974023 PMID:32479886 More...
|
|
NCBI chr 4:10,793,834...10,814,170
Ensembl chr 4:10,793,834...10,814,166
|
|
G |
Nppa |
natriuretic peptide A |
multiple interactions |
EXP |
Sildenafil Citrate inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA] |
CTD |
PMID:18790048 |
|
NCBI chr 5:158,429,042...158,430,351
Ensembl chr 5:158,429,042...158,430,351
|
|
G |
Nppb |
natriuretic peptide B |
affects expression multiple interactions |
ISO EXP |
Sildenafil Citrate affects the expression of NPPB protein Sildenafil Citrate inhibits the reaction [Phenylephrine results in increased expression of NPPB mRNA] |
CTD |
PMID:18790048 PMID:19179780 |
|
NCBI chr 5:158,416,813...158,418,175
Ensembl chr 5:158,416,866...158,418,168
|
|
G |
Pcna |
proliferating cell nuclear antigen |
multiple interactions |
EXP |
Sildenafil Citrate inhibits the reaction [Oxygen deficiency results in increased expression of PCNA mRNA]; Sildenafil Citrate inhibits the reaction [Oxygen deficiency results in increased expression of PCNA protein] |
CTD |
PMID:36940862 |
|
NCBI chr 3:119,499,039...119,502,911
Ensembl chr 3:119,498,810...119,502,995
|
|
G |
Pde5a |
phosphodiesterase 5A |
decreases activity multiple interactions |
ISO EXP |
Sildenafil Citrate results in decreased activity of PDE5A protein [Sildenafil Citrate co-treated with resveratrol] inhibits the reaction [Streptozocin results in increased expression of PDE5A protein] |
CTD |
PMID:8858389 PMID:10422958 PMID:15934858 PMID:16368379 PMID:17138653 PMID:18778098 PMID:19374906 PMID:26006044 More...
|
|
NCBI chr 2:210,858,515...211,003,480
Ensembl chr 2:210,858,063...210,999,701
|
|
G |
Pde8b |
phosphodiesterase 8B |
multiple interactions |
ISO |
Sildenafil Citrate inhibits the reaction [PDE8B protein results in increased metabolism of Cyclic AMP] |
CTD |
PMID:12681444 |
|
NCBI chr 2:26,275,117...26,479,725
Ensembl chr 2:26,276,635...26,509,209
|
|
G |
Pfkfb3 |
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 |
multiple interactions |
EXP |
Sildenafil Citrate inhibits the reaction [[Ethanol co-treated with Aflatoxin B1] results in increased expression of PFKFB3 mRNA] |
CTD |
PMID:35608386 |
|
NCBI chr17:66,983,629...67,064,702
Ensembl chr17:66,983,686...67,063,125
|
|
G |
Pparg |
peroxisome proliferator-activated receptor gamma |
multiple interactions increases expression |
ISO |
8-(4-chlorophenylthio)guanosine 3',5'-cyclic monophosphorothioate inhibits the reaction [Sildenafil Citrate results in increased expression of PPARG protein] Sildenafil Citrate results in increased expression of PPARG mRNA; Sildenafil Citrate results in increased expression of PPARG protein |
CTD |
PMID:20471953 |
|
NCBI chr 4:148,423,102...148,548,471
Ensembl chr 4:148,423,194...148,548,468
|
|
G |
Prkg1 |
protein kinase cGMP-dependent 1 |
multiple interactions increases response to substance |
ISO |
PRKG1 protein promotes the reaction [Sildenafil Citrate inhibits the reaction [AGT protein modified form results in increased expression of CCN2 mRNA]]; PRKG1 protein promotes the reaction [Sildenafil Citrate inhibits the reaction [AGT protein modified form results in increased expression of COL1A1 mRNA]]; PRKG1 protein promotes the reaction [Sildenafil Citrate inhibits the reaction [AGT protein modified form results in increased expression of FN1 mRNA]]; PRKG1 protein promotes the reaction [Sildenafil Citrate inhibits the reaction [AGT protein modified form results in increased expression of TGFB1 mRNA]] PRKG1 protein results in increased susceptibility to Sildenafil Citrate |
CTD |
PMID:25139994 |
|
NCBI chr 1:228,409,605...229,638,794
Ensembl chr 1:228,408,947...229,639,080
|
|
G |
Ren |
renin |
increases activity |
ISO |
Sildenafil Citrate results in increased activity of REN protein |
CTD |
PMID:15613622 |
|
NCBI chr13:44,796,260...44,807,491
Ensembl chr13:44,796,091...44,807,489
|
|
G |
Slc22a2 |
solute carrier family 22 member 2 |
multiple interactions |
ISO |
Sildenafil Citrate inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] |
CTD |
PMID:21599003 |
|
NCBI chr 1:48,121,061...48,163,268
Ensembl chr 1:48,121,061...48,163,268
|
|
G |
Slc2a1 |
solute carrier family 2 member 1 |
multiple interactions |
EXP |
Sildenafil Citrate inhibits the reaction [Aflatoxin B1 results in increased expression of SLC2A1 mRNA] |
CTD |
PMID:35608386 |
|
NCBI chr 5:132,717,196...132,745,416
Ensembl chr 5:132,717,196...132,745,416
|
|
G |
Slc2a4 |
solute carrier family 2 member 4 |
increases expression |
ISO |
Sildenafil Citrate results in increased expression of SLC2A4 mRNA; Sildenafil Citrate results in increased expression of SLC2A4 protein |
CTD |
PMID:20471953 |
|
NCBI chr10:54,666,015...54,671,581
Ensembl chr10:54,666,015...54,671,565
|
|
G |
Snca |
synuclein alpha |
multiple interactions |
EXP |
Sildenafil Citrate inhibits the reaction [[Aluminum Chloride results in increased abundance of Aluminum] which results in increased expression of SNCA protein] |
CTD |
PMID:32959702 |
|
NCBI chr 4:89,696,420...89,797,240
Ensembl chr 4:89,696,420...89,796,262
|
|
G |
Sod1 |
superoxide dismutase 1 |
decreases expression |
ISO |
Sildenafil Citrate results in decreased expression of SOD1 protein |
CTD |
PMID:38059649 |
|
NCBI chr11:29,456,673...29,462,249
Ensembl chr11:29,456,558...29,462,249
|
|
G |
Star |
steroidogenic acute regulatory protein |
multiple interactions |
EXP |
Sildenafil Citrate inhibits the reaction [NG-Nitroarginine Methyl Ester results in decreased expression of STAR protein] |
CTD |
PMID:32479886 |
|
NCBI chr16:66,267,094...66,274,368
Ensembl chr16:66,264,807...66,271,672
|
|
G |
Tgfb1 |
transforming growth factor, beta 1 |
multiple interactions |
ISO EXP |
PRKG1 protein promotes the reaction [Sildenafil Citrate inhibits the reaction [AGT protein modified form results in increased expression of TGFB1 mRNA]]; Sildenafil Citrate inhibits the reaction [AGT protein modified form results in increased expression of TGFB1 mRNA] Sildenafil Citrate inhibits the reaction [[Aflatoxin B1 co-treated with Ethanol] results in increased expression of TGFB1 mRNA] |
CTD |
PMID:25139994 PMID:35608386 |
|
NCBI chr 1:81,196,532...81,212,848
Ensembl chr 1:81,196,532...81,212,847
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions |
ISO EXP |
Sildenafil Citrate inhibits the reaction [4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone results in decreased expression of TNF protein] Sildenafil Citrate inhibits the reaction [[Aluminum Chloride results in increased abundance of Aluminum] which results in increased expression of TNF protein] |
CTD |
PMID:15169552 PMID:32959702 |
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Tp53 |
tumor protein p53 |
multiple interactions increases expression |
ISO |
TP53 protein inhibits the reaction [Sildenafil Citrate results in increased susceptibility to Doxorubicin] Sildenafil Citrate results in increased expression of TP53 protein |
CTD |
PMID:20155316 PMID:38059649 |
|
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
|
|
G |
Trpc1 |
transient receptor potential cation channel, subfamily C, member 1 |
multiple interactions |
ISO |
Sildenafil Citrate inhibits the reaction [EDN1 protein results in increased expression of TRPC1 mRNA] |
CTD |
PMID:18818482 |
|
NCBI chr 8:96,263,322...96,314,220
Ensembl chr 8:96,263,329...96,314,276
|
|
G |
Trpc6 |
transient receptor potential cation channel, subfamily C, member 6 |
increases phosphorylation |
ISO |
Sildenafil Citrate results in increased phosphorylation of TRPC6 protein |
CTD |
PMID:20177073 |
|
NCBI chr 8:5,759,387...5,864,000
Ensembl chr 8:5,758,935...5,828,092
|
|
G |
Tuba1a |
tubulin, alpha 1A |
increases expression |
ISO |
Sildenafil Citrate results in increased expression of TUBA1A mRNA |
CTD |
PMID:27015953 |
|
NCBI chr 7:130,113,214...130,116,880
Ensembl chr 7:130,081,032...130,196,186
|
|
G |
Txn1 |
thioredoxin 1 |
increases expression |
EXP |
Sildenafil Citrate results in increased expression of TXN1 |
CTD |
PMID:18373738 |
|
NCBI chr 5:72,712,334...72,724,564
Ensembl chr 5:72,711,933...72,724,629
|
|
G |
Vcam1 |
vascular cell adhesion molecule 1 |
multiple interactions |
EXP |
Sildenafil Citrate inhibits the reaction [[Aluminum Chloride results in increased abundance of Aluminum] which results in increased expression of VCAM1 protein] |
CTD |
PMID:32959702 |
|
NCBI chr 2:204,038,120...204,057,852
Ensembl chr 2:204,038,114...204,057,958
|
|
G |
Vegfa |
vascular endothelial growth factor A |
increases expression multiple interactions |
EXP |
Sildenafil Citrate results in increased expression of VEGFA mRNA; Sildenafil Citrate results in increased expression of VEGFA protein Sildenafil Citrate inhibits the reaction [[Aluminum Chloride results in increased abundance of Aluminum] which results in decreased expression of VEGFA protein]; Sildenafil Citrate inhibits the reaction [Aflatoxin B1 results in increased expression of VEGFA mRNA]; Sildenafil Citrate inhibits the reaction [alpha-naphthyl thiourea results in increased expression of VEGFA mRNA]; Sildenafil Citrate inhibits the reaction [alpha-naphthyl thiourea results in increased expression of VEGFA protein] |
CTD |
PMID:18373738 PMID:20583517 PMID:30974023 PMID:32959702 PMID:35608386 |
|
NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641
|
|
G |
Vegfb |
vascular endothelial growth factor B |
increases expression |
EXP |
Sildenafil Citrate results in increased expression of VEGFB mRNA |
CTD |
PMID:20583517 |
|
NCBI chr 1:204,172,297...204,178,046
Ensembl chr 1:204,172,225...204,177,944
|
|
G |
Vegfc |
vascular endothelial growth factor C |
increases expression |
EXP |
Sildenafil Citrate results in increased expression of VEGFC mRNA |
CTD |
PMID:20583517 |
|
NCBI chr16:37,712,251...37,827,845
Ensembl chr16:37,712,262...37,827,848
|
|